Mechanism of the malabaricone C-induced toxicity to the MCF-7 cell line

References

• Adjei AA, Rowinsky EK. Novel anticancer agents in clinical development. Cancer Biol Ther 2003;2:S5–S15.
   Google Scholar
• Neidle S, Thurston DE. Chemical approaches to the discovery and development of cancer therapies. Nat Rev Cancer 2005; 5:285–296.
   PubMed Web of Science ®Google Scholar
• Kamb A, Wee S, Lengauer C. Why is cancer drug discovery so difficult?Nat Rev Drug Discov 2007;6:115–120.
   PubMed Web of Science ®Google Scholar
• Pujol MD, Romero M, Sanchez I. Synthesis and biological activity of a new class of deoxygenated anticancer agents. Curr Med Chem Anticancer Agents 2005;5:215–237.
   PubMedGoogle Scholar
• Willett WC. Balancing life-style and genomics research for disease prevention. Science 2002;296:695–698.
   PubMed Web of Science ®Google Scholar
• Ralph SJ, Low P, Dong L, Lawen A, Neuzil J. Mitocans: mitochondrial targeted anti-cancer drugs as improved therapies and related patents documents. Recent Pat Anticancer Drug Discov 2006;1:327–346.
   PubMedGoogle Scholar
• Keshavamurthy KR. Medicinal plants of Karnataka: Karnataka Forest Department (ed.). Bangalore: India; 1994. pp. 223–224.
   Google Scholar
• Manjunatha BK, Mankani KL, Mukunda SK, Divakara R, Sridar BK, Paul K. Antioxidant and hepato protective effect of Myristica malabarica seed aril extracts on carbon tetrachloride induced hepatic damage. Global J Biotechnol Biochem 2011;6:25–30.
   Google Scholar
• Manjunatha BK, Hegde V, Abhilash N, Divakara R. Evaluation of in vitro antioxidant and in vivo hepatoprotective potency of Myristica malabarica. Res J Pharm Biol Chem Sci 2012;3:1044–1052.
   Google Scholar
• Kirtikar KR, Basu BD. Indian medicinal plants. Vol. 1, Periodical experts. Delhi: Jayyed Press; 1975.
   Google Scholar
• Palani V, Senthilkumaran RK, Govindasamy BS. Biochemical evaluation of antitumor effect of Muthu Marunthu (a herbal formulation) on experimental fibrosarcoma in rats. J Ethnopharmacol 1999;65:257–265.
   PubMed Web of Science ®Google Scholar
• Purushothaman KK, Sarada A, Connolly JD. Malabaricones A-D novel diarylnonanoids from Myristica malabarica Lam. J Chem Soc 1977;5:587–588.
   Google Scholar
• Patro BS, Bauri AK, Mishra S, Chattopadhyay S. Antioxidant activity of Myristica malabarica extracts and their constituents. J Agric Food Chem 2005;53:6912–6918.
   PubMed Web of Science ®Google Scholar
• Banerjee D, Bauri AK, Guha RK, Bandyopadhyay SK, Chattopadhyay S. Healing properties of malabaricone B and malabaricone C, against indomethacin-induced gastric ulceration and mechanism of action. Eur J Pharmacol 2008;578: 300–312.
   PubMed Web of Science ®Google Scholar
• Maity B, Yadav SK, Patro BS, Tyagi M, Bandyopadhyay SK, Chattopadhyay S. Molecular mechanism of the anti- inflammatory activity of a natural diarylnonanoid, malabaricone C. Free Radic Biol Med 2012;52:1680–1691.
   PubMed Web of Science ®Google Scholar
• Tyagi M, Bhattacharyya R, Bauri AK, Patro BS, Chattopadhyay S. DNA damage dependent activation of CHK1 and MAPK-p38 are required in malabaricone C-induced mitochondrial cell death. Biochim Biophys Acta (General) 2014;1840:1014–1027.
   PubMedGoogle Scholar
• Simstein R, Burow M, Parker A, Weldon C, Beckman B. Apoptosis, chemoresistance, and breast cancer: insights from the MCF-7 cell model system. Exp Biol Med 2003;228: 995–1003.
   PubMed Web of Science ®Google Scholar
• Jemal A, Siegel R, Ward E, Murray T, Xu J, Smigal C, Thun MJ. Cancer statistics, 2006. CA Cancer J Clin 2006;56:106–130.
   PubMed Web of Science ®Google Scholar
• Patro BS, Tyagi M, Saha J, Chattopadhyay S. Comparative nuclease and anti-cancer properties of the naturally occurring malabaricones. Bioorg Med Chem 2010;18:7043–7051.
   PubMedGoogle Scholar
• Burrows CJ, Muller JG. Oxidative nucleobase modifications leading to strand scission. Chem Rev 1998;98:1109–1151.
   PubMed Web of Science ®Google Scholar
• Ashkenazi A, Dixit VM. Death receptors: Signaling and modulation. Science 1998;281:1305–1308.
   PubMed Web of Science ®Google Scholar
• Nagata S. Apoptosis by death factor. Cell 1997; 88:355–365.
   PubMed Web of Science ®Google Scholar
• Dougherty TJ, Gomer CJ, Henderson BW, Jori G, Kessel D, Korbelik M, et al. Photodynamic therapy. J Natl Cancer Inst 1998;90:889–905.
   PubMed Web of Science ®Google Scholar
• Tait SWG, Green DR. Mitochondria and cell death: outer membrane permeabilization and beyond. Nat Rev Mol Cell Biol 2010;11:621–632.
   PubMed Web of Science ®Google Scholar
• Jänicke RU. MCF-7 breast carcinoma cells do not express caspase-3. Breast Cancer Res Treat 2009;117:219–221.
   PubMed Web of Science ®Google Scholar
• Johansson AC, Appelqvist H, Nilsson C, Kågedal K, Roberg K, Öllinger K. Regulation of apoptosis-associated lysosomal membrane permeabilization. Apoptosis 2010;15:527–540.
   PubMed Web of Science ®Google Scholar
• Repnik U, Stoka V, Turk V, Turk B. Lysosomes and lysosomal cathepsins in cell death. Biochim Biophys Acta 2012;1824: 22–33.
   PubMed Web of Science ®Google Scholar
• Orrenius S, Zhivotovsky B, Nicotera P. Regulation of cell death: the calcium–apoptosis link. Nat Rev Mol Cell Biol 2003;4:552–565.
   PubMed Web of Science ®Google Scholar
• Guha P, Dey A, Dhyani MV, Sen R, Chatterjee M, Chattopadhyay S, Bandyopadhyay SK. Calpain and caspase orchestrated death signal to accomplish apoptosis induced by resveratrol and its novel analog HST-1 in cancer cells. J Pharmacol Exp Ther 2010;334:381–394.
   PubMedGoogle Scholar
• Daugas E, Susin SA, Zamzami N, Ferri KF, Irinopoulou T, Larochette N, et al. Mitochondrio-nuclear translocation of AIF in apoptosis and necrosis. FASEB J 2000;730:729–739.
   Google Scholar
• Bossy-Wetzel E, Green DR. Caspases induce cytochrome c release from mitochondria by activating cytosolic factors. J Biol Chem 1999;274:17484–17490.
   PubMed Web of Science ®Google Scholar
• Green DR, Reed JC. Mitochondria and apoptosis. Science 1998;281:1309–1312.
   PubMed Web of Science ®Google Scholar
• Modjtahedi N, Giordanetto F, Madeo F, Kroemer G. Apoptosis-inducing factor: vital and lethal. Trends Cell Biol 2006;16:264–272.
   PubMed Web of Science ®Google Scholar
• Li LY, Luo X, Wang X. Endonuclease G is an apoptotic DNase when released from mitochondria. Nature 2001;412:95–99.
   PubMed Web of Science ®Google Scholar
• Monteith GR, McAndrew D, Faddy HM, Roberts-Thomson SJ. Calcium and cancer: targeting Ca2+ transport. Nat Rev Cancer 2007;7:519–530.
   PubMed Web of Science ®Google Scholar
• Ferri KF, Kroemer G. Organelle-specific initiation of cell death pathways. Nat Cell Biol 2001;3:E255–E263.
   PubMed Web of Science ®Google Scholar
• Lamparska-Przybysz M, Gajkowska B, Motyl T. BID-deficient breast cancer MCF-7 cells as a model for the study of autophagy in cancer therapy. Autophagy 2006;2:47–48.
   PubMed Web of Science ®Google Scholar
• Shelton SN, Shawgo ME, Robertson JD. Cleavage of Bid by executioner caspases mediates feed forward amplification of mitochondrial outer membrane permeabilization during genotoxic stress-induced apoptosis in Jurkat cells. J Biol Chem 2009;284:11247–11255.
   PubMed Web of Science ®Google Scholar
• Zinkel SS, Hurov KE, Ong C, Abtahi FM, Gross A, Korsmeyer SJ. A role for proapoptotic BID in the DNA- damage response. Cell 2005;122:579–591.
   PubMed Web of Science ®Google Scholar
• Kroemer G, Galluzzi L, Brenner C. Mitochondrial membrane permeabilization in cell death. Physiol Rev 2007;87:99–163.
   PubMed Web of Science ®Google Scholar
• Anguissola S, Köhler B, O’Byrne R, Düssmann H, Cannon MD, Murray FE, et al. Bid and calpains cooperate to trigger oxaliplatin-induced apoptosis of cervical carcinoma HeLa cells. Mol Pharmacol 2009;76:998–1010.
   PubMedGoogle Scholar
• Terman A, Kurz T, Gustafsson B, Brunk UT. Lysosomal labilization. IUBMB Life 2006;58:531–539.
   PubMed Web of Science ®Google Scholar
• Stoka V, Turk B, Schendel SL, Kim TH, Cirman T, Snipas SJ, et al. Lysosomal protease pathways to apoptosis. J Biol Chem 2001;276:3149–3157.
   PubMed Web of Science ®Google Scholar
• Owa T, Yoshino H, Yoshimatsu K, Nagasu T. Cell cycle regulation in the G1 phase: a promising target for the development of new chemotherapeutic anticancer agents. Curr Med Chem 2001;8:1487–1503.
   PubMed Web of Science ®Google Scholar
• Lepoivre M, Elleingand E, Gerez C, Guittet O. Resveratrol, a remarkable inhibitor of ribonucleotide reductase. FEBS Lett 1998;421:277–279.
   PubMedGoogle Scholar
• Sherr CJ. Cancer cell cycles. Science 1996;274:1672–1677.
   PubMed Web of Science ®Google Scholar
• Yam CH, Fung TK, Poon RY. Cyclin A in cell cycle control and cancer. Cell Mol Life Sci 2002;59:1317–1326.
   PubMed Web of Science ®Google Scholar
• Kawashima R, Haisa M, Kimura M, Takaoka M, Shirakawa Y, Takeda H, et al. Cyclin A correlates with the sensitivity of human cancer cells to cytotoxic effects of 5-FU. Int J Oncol 2004;24:273–278.
   PubMed Web of Science ®Google Scholar
• Porter PL, Malone KE, Heagerty PJ, Alexander GM, Gatti LA, Firpo EJ, et al. Expression of cell-cycle regulators p27Kip1 and cyclin E, alone and in combination, correlate with survival in young breast cancer patients. Nat Med 1997;3:222–225.
   PubMed Web of Science ®Google Scholar
• Karlsson M, Jungnelius U, Aamdal S, Boeryd B, Carstensen J, Kågedal B, et al. Correlation of DNA ploidy and S-phase fraction with chemotherapeutic response and survival in a randomized study of disseminated malignant melanoma. Int J Cancer 1996;65:1–5.
   PubMedGoogle Scholar
• Erdal H, Berndtsson M, Castro J, Brunk U, Shoshan MC, Linder S. Induction of lysosomal membrane permeabilization by compounds that activate p53-independent apoptosis. Proc Natl Acad Sci USA 2005;102:192–197.
   PubMed Web of Science ®Google Scholar